Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFLORES-CHAVEZ, A.
dc.contributor.authorNG, W-F
dc.contributor.authorALUNNO, A.
dc.contributor.authorINANC, N.
dc.contributor.authorFEIJOO-MASSO, C.
dc.contributor.authorSEROR, R.
dc.contributor.authorHERNANDEZ-MOLINA, G.
dc.contributor.authorDEVAUCHELLE-PENSEC, V.
dc.contributor.authorHOFAUER, B.
dc.contributor.authorPASOTO, S. G.
dc.contributor.authorROBLES, A.
dc.contributor.authorAKASBI, M.
dc.contributor.authorLOPEZ-DUPLA, M.
dc.contributor.authorRETAMOZO, S.
dc.contributor.authorBANDEIRA, M.
dc.contributor.authorROMAO, V. C.
dc.contributor.authorCARUBBI, F.
dc.contributor.authorLOAIZA-CABELLO, D.
dc.contributor.authorGARCIA-MORILLO, J. -S.
dc.contributor.authorBENEGAS, M.
dc.contributor.authorSANCHEZ, M.
dc.contributor.authorMUXI, A.
dc.contributor.authorFUSTER, D.
dc.contributor.authorSELLARES, J.
dc.contributor.authorMARIETTE, X.
dc.contributor.authorRAMOS-CASALS, M.
dc.contributor.authorBRITO-ZERON, P.
dc.contributor.groupauthorSarco-GEAS-SEMI
dc.contributor.groupauthorSjogren Big Data Consortium
dc.date.accessioned2023-06-21T14:20:09Z
dc.date.available2023-06-21T14:20:09Z
dc.date.issued2022
dc.description.abstractObjective To characterise the key epidemiological, clinical, immunological, imaging, and pathological features of the coexistence between sarcoidosis and Sjogren's syndrome (SS). Methods All centres included in two large multicentre registries (the Sjogren Syndrome Big Data Consortium and the Sarco-GEAS-SEMI Registry) were contacted searching for potential cases of coexistence between SS and sarcoidosis seen in daily practice. Inclusion criteria were the fulfilment of the current classification criteria both for SS (2016 ACR/EULAR) and sarcoidosis (WASOG). The following features were considered for evaluating a coexisting immunopathological scenario between the two diseases: non-caseating granulomas (NCG), focal lymphocytic sialadenitis (FLS) and positive anti-Ro antibodies. Results We identified 43 patients who fulfilled the inclusion criteria (38 women, with a mean age of 53 years at diagnosis of SS and of 52 years at diagnosis of sarcoidosis). In 28 (65%) cases, sarcoidosis was diagnosed concomitantly with SS, or during the follow-up of patients with an already diagnosed SS, while in the remaining 15 (35%), SS was diagnosed during the follow-up of an already diagnosed sarcoidosis. Patients in whom sarcoidosis was diagnosed first showed a lower mean age (43.88 vs. 55.67 years, p=0.005) and were less frequently women (73% vs. 96%, p=0.04) in comparison with those in whom sarcoidosis was diagnosed concomitantly with SS, or during the follow-up of an already diagnosed SS. We identified the following immunopathological scenarios: a combination of NCG involving extrasalivary tissues and anti-Ro antibodies in 55% of patients, a coexistence of both pathological scenarios (extrasalivary NCG and FLS in MSGB) in 42% (with positive anti-Ro antibodies in two thirds of cases), and NCG involving salivary glands and anti-Ro antibodies in 3% of cases. Conclusion We have characterised the largest reported series of patients who fulfilled the current classification criteria for both SS and sarcoidosis. This implies that sarcoidosis (and not just the presence of isolated NCG on salivary gland biopsy) may, like other systemic autoimmune diseases, coexist with SS, and that a sarcoidosis diagnosis does not preclude the development of SS in the future.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.40, n.12, p.2329-2337, 2022
dc.identifier.doi10.55563/clinexprheumatol/pg964c
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/54171
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGYeng
dc.relation.ispartofClinical and Experimental Rheumatology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright CLINICAL & EXPER RHEUMATOLOGYeng
dc.subjectsarcoidosiseng
dc.subjectSjogren's syndromeeng
dc.subjectcoexistence of autoimmune diseaseseng
dc.subject.otherdiseaseeng
dc.subject.otherrecommendationseng
dc.subject.otherclassificationeng
dc.subject.otherdiagnosiseng
dc.subject.othercriteriaeng
dc.subject.otherupdateeng
dc.subject.wosRheumatologyeng
dc.titleCharacterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patientseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryMéxico
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryPortugal
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryTurquia
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisotr
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisomx
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisopt
hcfmusp.author.externalFLORES-CHAVEZ, A.:GRESS AGAUR, Sjogren Syndrome Res Grp, Barcelona, Spain; Hosp Clin Barcelona, Dept Autoimmune Dis, ICMiD, Barcelona, Spain; Univ Barcelona, Barcelona, Spain
hcfmusp.author.externalNG, W-F:United Kingdom Primary Sjogrens Syndrome Registry, London, England
hcfmusp.author.externalALUNNO, A.:Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; San Salvatore Hosp, Dept Med, Internal Med & Nephrol Unit, ASL Avezzano Sulmona Laquila, Laquila, Italy
hcfmusp.author.externalINANC, N.:Marmara Univ, Sch Med, Istanbul, Turkey
hcfmusp.author.externalFEIJOO-MASSO, C.:Hosp Parc Tauli, Internal Med, Sabadell, Spain
hcfmusp.author.externalSEROR, R.:Univ Paris Saclay, Paris, France
hcfmusp.author.externalHERNANDEZ-MOLINA, G.:Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Dept, Mexico City, DF, Mexico
hcfmusp.author.externalDEVAUCHELLE-PENSEC, V.:Cavale Blanche Univ Hosp, Brest, France
hcfmusp.author.externalHOFAUER, B.:Univ Hosp, Klinikum Rechts Isar, Munich, Germany
hcfmusp.author.externalROBLES, A.:Hosp La Paz, Med, Madrid, Spain
hcfmusp.author.externalAKASBI, M.:Hosp Infanta Leonor, Dept Internal Med, Madrid, Spain
hcfmusp.author.externalLOPEZ-DUPLA, M.:Hosp Univ Joan XXIII, Dept Internal Med, Tarragona, Spain
hcfmusp.author.externalRETAMOZO, S.:GRESS AGAUR, Sjogren Syndrome Res Grp, Barcelona, Spain
hcfmusp.author.externalBANDEIRA, M.:Ctr Hosp Univ Lisboa Norte, Dept Rheumatol, CAML, Lisbon, Portugal; Univ Lisbon, Fac Med, CAML, Rheumatol Res Unit,Inst Med Mol, Lisbon, Portugal
hcfmusp.author.externalROMAO, V. C.:Ctr Hosp Univ Lisboa Norte, Dept Rheumatol, CAML, Lisbon, Portugal; Univ Lisbon, Fac Med, CAML, Rheumatol Res Unit,Inst Med Mol, Lisbon, Portugal
hcfmusp.author.externalLOAIZA-CABELLO, D.:Hosp Virgen del Rocio, Dept Internal Med, Syst Autoimmune & Rare Dis Unit, Seville, Spain
hcfmusp.author.externalGARCIA-MORILLO, J. -S.:Hosp Virgen del Rocio, Dept Internal Med, Syst Autoimmune & Rare Dis Unit, Seville, Spain
hcfmusp.author.externalBENEGAS, M.:Hosp Clin Barcelona, Dept Radiol, Ctr Diagnost Imatge Clin, Barcelona, Spain
hcfmusp.author.externalSANCHEZ, M.:Hosp Clin Barcelona, Dept Radiol, Ctr Diagnost Imatge Clin, Barcelona, Spain
hcfmusp.author.externalMUXI, A.:Univ Barcelona, Hosp Clin, Dept Nucl Med, Barcelona, Spain
hcfmusp.author.externalFUSTER, D.:Univ Barcelona, Hosp Clin, Dept Nucl Med, Barcelona, Spain
hcfmusp.author.externalSELLARES, J.:Univ Barcelona, Hosp Clin, Resp Inst, Barcelona, Spain
hcfmusp.author.externalMARIETTE, X.:Univ Paris Saclay, Paris, France
hcfmusp.author.externalRAMOS-CASALS, M.:Hosp Clin Barcelona, Dept Autoimmune Dis, ICMiD, Barcelona, Spain; Univ Barcelona, Barcelona, Spain
hcfmusp.author.externalBRITO-ZERON, P.:Milenium Balmes Hosp CIMA Sanitas, Res & Innovat Grp Autoimmune Dis, Barcelona, Spain
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcSANDRA GOFINET PASOTO
hcfmusp.description.beginpage2329
hcfmusp.description.endpage2337
hcfmusp.description.issue12
hcfmusp.description.volume40
hcfmusp.origemWOS
hcfmusp.origem.pubmed36541233
hcfmusp.origem.scopus2-s2.0-85144271742
hcfmusp.origem.wosWOS:000965808100019
hcfmusp.publisher.cityPISAeng
hcfmusp.publisher.countryITALYeng
hcfmusp.relation.referenceAcar-Denizli N, 2019, CLIN EXP RHEUMATOL, V37, pS19eng
hcfmusp.relation.referenceAnaya JM, 2014, AUTOIMMUN REV, V13, P423, DOI 10.1016/j.autrev.2014.01.049eng
hcfmusp.relation.referenceBrito-Zeron P, 2019, CLIN EXP RHEUMATOL, V37, P1052eng
hcfmusp.relation.referenceBrito-Zeron P, 2021, JOINT BONE SPINE, V88, DOI 10.1016/j.jbspin.2021.105236eng
hcfmusp.relation.referenceBrito-Zeron P, 2020, RHEUMATOLOGY, V59, P2350, DOI 10.1093/rheumatology/kez578eng
hcfmusp.relation.referenceBrito-Zeron P, 2018, LUNG, V196, P239, DOI 10.1007/s00408-017-0076-4eng
hcfmusp.relation.referenceBrito-Zeron P, 2016, EXPERT OPIN PHARMACO, V17, P2431, DOI 10.1080/14656566.2016.1258061eng
hcfmusp.relation.referenceBrito-Zeron P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.47eng
hcfmusp.relation.referenceCui David, 2020, Am J Ophthalmol Case Rep, V19, P100790, DOI 10.1016/j.ajoc.2020.100790eng
hcfmusp.relation.referenceDrosos AA, 1999, RHEUMATOL INT, V18, P177, DOI 10.1007/s002960050081eng
hcfmusp.relation.referenceGal I, 2000, J RHEUMATOL, V27, P2507eng
hcfmusp.relation.referenceGIOTAKI H, 1986, RESPIRATION, V50, P102, DOI 10.1159/000194916eng
hcfmusp.relation.referenceHansen SR, 2008, SCAND J RHEUMATOL, V37, P485, DOI 10.1080/03009740802220075eng
hcfmusp.relation.referenceHernandez-Molina G, 2022, RHEUMATOLOGY, V62, P243, DOI 10.1093/rheumatology/keac205eng
hcfmusp.relation.referenceInoue Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143371eng
hcfmusp.relation.referenceJimenez-Royo P, 2021, RHEUMATOLOGY, V60, P2396, DOI 10.1093/rheumatology/keaa624eng
hcfmusp.relation.referenceJudson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19eng
hcfmusp.relation.referenceKeraen J, 2019, ARTHRITIS RHEUMATOL, V71, P1147, DOI 10.1002/art.40829eng
hcfmusp.relation.referenceLaw ST, 2020, ARTHRIT CARE RES, V72, P1466, DOI 10.1002/acr.24029eng
hcfmusp.relation.referenceLower EE, 2020, CLIN EXP RHEUMATOL, V38, P834eng
hcfmusp.relation.referenceMansour MJ, 2007, J ORAL PATHOL MED, V36, P337, DOI 10.1111/j.1600-0714.2007.00530.xeng
hcfmusp.relation.referenceMansour MJ, 2013, J ORAL PATHOL MED, V42, P594, DOI 10.1111/jop.12057eng
hcfmusp.relation.referenceNakamura T, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.22827eng
hcfmusp.relation.referencePerez-Alvarez R, 2019, EUR J INTERN MED, V69, P77, DOI 10.1016/j.ejim.2019.08.025eng
hcfmusp.relation.referencePiekarski E, 2018, SEMIN NUCL MED, V48, P246, DOI 10.1053/j.semnuclmed.2018.02.005eng
hcfmusp.relation.referenceRamos-Casals M, 2004, MEDICINE, V83, P85, DOI 10.1097/01.md.0000121237.98962.1eeng
hcfmusp.relation.referenceRamos-Casals M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92967-6eng
hcfmusp.relation.referenceRamos-Casals M, 2020, ANN RHEUM DIS, V79, P3, DOI 10.1136/annrheumdis-2019-216114eng
hcfmusp.relation.referenceRamos-Casals M, 2019, LUNG, V197, P427, DOI 10.1007/s00408-019-00243-2eng
hcfmusp.relation.referenceRamos-Casals M, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e3821, 10.1024/1661-8157/a001133]eng
hcfmusp.relation.referenceRamos-Casals M, 2015, RHEUMATOLOGY, V54, P2230, DOI 10.1093/rheumatology/kev200eng
hcfmusp.relation.referenceRetamozo S, 2021, CLIN EXP RHEUMATOL, V39, pS166eng
hcfmusp.relation.referenceROSS JA, 1955, BRIT MED J, V2, P593, DOI 10.1136/bmj.2.4939.593eng
hcfmusp.relation.referenceSantiago T, 2014, RHEUMATOL INT, V34, P1619, DOI 10.1007/s00296-014-3024-0eng
hcfmusp.relation.referenceSCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165eng
hcfmusp.relation.referenceSeror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615eng
hcfmusp.relation.referenceShiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]eng
hcfmusp.relation.referenceTerwiel M, 2019, CURR OPIN PULM MED, V25, P539, DOI 10.1097/MCP.0000000000000598eng
hcfmusp.relation.referenceTokuyasu H, 2008, INTERNAL MED, V47, P2049, DOI 10.2169/internalmedicine.47.1526eng
hcfmusp.relation.referencevan de Loosdrecht AA, 2001, RHEUMATOLOGY, V40, P113, DOI 10.1093/rheumatology/40.1.113eng
hcfmusp.relation.referenceVITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309eng
hcfmusp.relation.referenceWu CH, 2017, J DERMATOL, V44, P423, DOI 10.1111/1346-8138.13654eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication6032e83a-1e45-4687-b844-e1ef69997c95
relation.isAuthorOfPublication.latestForDiscovery6032e83a-1e45-4687-b844-e1ef69997c95
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_FLORES-CHAVEZ_Characterisation_of_the_coexistence_between_sarcoidosis_and_Sjogrens_2022.PDF
Tamanho:
1.6 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - ODS/03